Zevra Therapeutics (ZVRA) Capital Leases (2014 - 2018)
Zevra Therapeutics' (ZVRA) quarterly Capital Leases came in at $396000.0 in Q4 2018, down 29.54% YoY from $562000.0 in Q4 2017, and down 12.2% on a QoQ basis from $451000.0 in Q3 2018.
Zevra Therapeutics (ZVRA) Capital Leases (2014 - 2018) Analysis & Trends
Zevra Therapeutics (ZVRA) has 5 years of Capital Leases data on file, last reported at $396000.0 in Q4 2018.
- Quarterly Capital Leases fell 29.54% year-over-year to $396000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $396000.0 (down 29.54% YoY) and the FY2018 annual result came in at $396000.0, down 29.54% from the prior year.
- Capital Leases eased to $396000.0 in Q4 2018, from $451000.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $657000.0 in Q4 2016 to a low of $3000.0 in Q3 2015.
- A 5-year average of $310500.0 and a median of $423500.0 in 2018 frame the typical range for Capital Leases.
- Annual changes were most pronounced in 2017 — Capital Leases declined 14.46% — and 2018, when it slipped 29.54%.
- Tracing ZVRA's Capital Leases over 5 years: stood at $26000.0 in 2014, then sank by 88.46% to $3000.0 in 2015, then surged by 21800.0% to $657000.0 in 2016, then dropped by 14.46% to $562000.0 in 2017, then decreased by 29.54% to $396000.0 in 2018.
- The last three Capital Leases figures came in at $396000.0 (Q4 2018), $451000.0 (Q3 2018), and $466000.0 (Q2 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Zevra Therapeutics | 671.75 Mn | 450.18 Mn | 38.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 396,000.00 |
| Sep 30, 2018 | 451,000.00 |
| Jun 30, 2018 | 466,000.00 |
| Mar 31, 2018 | 515,000.00 |
| Dec 31, 2017 | 562,000.00 |
| Dec 31, 2016 | 657,000.00 |
| Sep 30, 2015 | 3,000.00 |
| Jun 30, 2015 | 11,000.00 |
| Mar 31, 2015 | 18,000.00 |
| Dec 31, 2014 | 26,000.00 |